Follow
Jeremie Nsengimana
Jeremie Nsengimana
Verified email at newcastle.ac.uk
Title
Cited by
Cited by
Year
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer
C Turnbull, EA Rapley, S Seal, D Pernet, A Renwick, D Hughes, ...
Nature genetics 42 (7), 604-607, 2010
3762010
A genome-wide association study of testicular germ cell tumor
EA Rapley, C Turnbull, AA Al Olama, ET Dermitzakis, R Linger, ...
Nature genetics 41 (7), 807-810, 2009
3692009
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14
E Ruark, S Seal, H McDonald, F Zhang, A Elliot, KW Lau, E Perdeaux, ...
Nature genetics 45 (6), 686-689, 2013
1652013
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor
K Litchfield, M Levy, G Orlando, C Loveday, PJ Law, G Migliorini, ...
Nature genetics 49 (7), 1133-1140, 2017
1412017
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival
C Conway, A Mitra, R Jewell, J Randerson-Moor, S Lobo, J Nsengimana, ...
Clinical cancer research 15 (22), 6939-6946, 2009
1142009
Vitamin D–VDR signaling inhibits Wnt/β-catenin–mediated melanoma progression and promotes antitumor immunity
S Muralidhar, A Filia, J Nsengimana, J Poźniak, SJ O'Shea, JM Diaz, ...
Cancer research 79 (23), 5986-5998, 2019
1012019
Linkage disequilibrium in the domesticated pig
J Nsengimana, P Baret, CS Haley, PM Visscher
Genetics 166 (3), 1395-1404, 2004
972004
β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas
J Nsengimana, J Laye, A Filia, S O’Shea, S Muralidhar, J Poźniak, ...
The Journal of clinical investigation 128 (5), 2048-2063, 2018
912018
Patterns of expression of DNA repair genes and relapse from melanoma
R Jewell, C Conway, A Mitra, J Randerson-Moor, S Lobo, J Nsengimana, ...
Clinical cancer research 16 (21), 5211-5221, 2010
782010
Melanoma sentinel node biopsy and prediction models for relapse and overall survival
A Mitra, C Conway, C Walker, M Cook, B Powell, S Lobo, M Chan, ...
British journal of cancer 103 (8), 1229-1236, 2010
782010
Factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas: development and external validation of a predictive nomogram
A Maurichi, R Miceli, H Eriksson, J Newton-Bishop, J Nsengimana, ...
Journal of Clinical Oncology 38 (14), 1591-1601, 2020
682020
Large-scale sequencing of testicular germ cell tumour (TGCT) cases excludes major TGCT predisposition gene
K Litchfield, C Loveday, M Levy, D Dudakia, E Rapley, J Nsengimana, ...
European urology 73 (6), 828-831, 2018
682018
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
HJ Close, LF Stead, J Nsengimana, KA Reilly, A Droop, H Wurdak, ...
Clinical & Experimental Immunology 200 (1), 33-44, 2020
652020
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy
R Abbotts, R Jewell, J Nsengimana, DJ Maloney, A Simeonov, ...
Oncotarget 5 (10), 3273, 2014
642014
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation
NR Campbell, A Rao, MV Hunter, MK Sznurkowska, L Briker, M Zhang, ...
Developmental cell 56 (20), 2808-2825. e10, 2021
582021
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
J Nsengimana, J Laye, A Filia, C Walker, R Jewell, JJ Van den Oord, ...
Oncotarget 6 (13), 11683, 2015
582015
Genetic and environmental determinants of immune response to cutaneous melanoma
J Poźniak, J Nsengimana, JP Laye, SJ O’Shea, JMS Diaz, AP Droop, ...
Cancer research 79 (10), 2684-2696, 2019
572019
Tumour gene expression signature in primary melanoma predicts long-term outcomes
M Garg, DL Couturier, J Nsengimana, NA Fonseca, M Wongchenko, ...
Nature communications 12 (1), 1137, 2021
562021
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
MTW Teo, L Dyrskjøt, J Nsengimana, C Buchwald, H Snowden, J Morgan, ...
Annals of oncology 25 (4), 877-883, 2014
532014
The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma
M Shelton, CA Anene, J Nsengimana, W Roberts, J Newton-Bishop, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (1), 188456, 2021
522021
The system can't perform the operation now. Try again later.
Articles 1–20